These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30824644)

  • 1. Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis.
    Lopez-Olivo MA; Negrón JB; Zogala RJ; Carmona L; Criner K; Goel N; Gonzalez-Lopez L; Ingegnoli F; Leong A; March L; Shea B; Strand V; Tugwell P; Westrich-Robertson T; Zamora NV; Christensen R; Suarez-Almazor ME
    J Rheumatol; 2019 Sep; 46(9):1164-1167. PubMed ID: 30824644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report.
    Zamora NV; Christensen R; Goel N; Klokker L; Lopez-Olivo MA; Kristensen LE; Carmona L; Strand V; Curtis JR; Suarez-Almazor ME
    J Rheumatol; 2017 Dec; 44(12):1894-1898. PubMed ID: 28620065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
    Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH
    J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
    Benavent D; Carmona L; Lopez-Olivo MA; Hill CL; Westrich-Robertson T; Goel N; Strand V; Shea B; Grosskleg S; Leong A; Hofstetter C; Bingham C; Meyer D; Constien D; Berthelsen DB; Schultz G; de Groot I; Weiner J; Mather K; de Wit M; Böhm P; Cembalo SM; Tugwell P; Bruera S; Suarez-Almazor ME
    Semin Arthritis Rheum; 2024 Feb; 64():152343. PubMed ID: 38118370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session.
    Chapman LS; Jones J; Redmond AC; Flurey CA; Richards P; Hofstetter C; Smith TO; Arnold JB; Hannan MT; Maxwell LJ; Menz HB; Shea B; Golightly YM; Tugwell P; Beaton D; Conaghan PG; Helliwell PS; Siddle HJ
    Semin Arthritis Rheum; 2023 Aug; 61():152210. PubMed ID: 37156170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies.
    Kloppenburg M; Bøyesen P; Visser AW; Haugen IK; Boers M; Boonen A; Conaghan PG; Hawker GA; Kvien TK; Landewé R; Uhlig T; Smeets W; Greibrokk E; van der Heijde DM
    J Rheumatol; 2015 Nov; 42(11):2190-7. PubMed ID: 26136489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.
    Bartlett SJ; Bykerk VP; Cooksey R; Choy EH; Alten R; Christensen R; Furst DE; Guillemin F; Halls S; Hewlett S; Leong AL; Lyddiatt A; March L; Montie P; Orbai AM; Pohl C; Voshaar MS; Woodworth TG; Bingham CO
    J Rheumatol; 2015 Nov; 42(11):2185-9. PubMed ID: 25684764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
    Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
    J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review.
    Lopez-Olivo MA; Zogala RJ; des Bordes J; Zamora NV; Christensen R; Rai D; Goel N; Carmona L; Pratt G; Strand V; Suarez-Almazor ME
    Arthritis Care Res (Hoboken); 2021 May; 73(5):649-657. PubMed ID: 32004421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
    Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
    J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12.
    van Tuyl LH; Sadlonova M; Davis B; Flurey C; Goel N; Hewlett SE; Hill CL; Hoogland W; Kirwan JR; van Schaardenburg D; Scholte-Voshaar M; Smolen JS; Stamm T; Wells GA; Boers M
    J Rheumatol; 2016 Jan; 43(1):203-7. PubMed ID: 25684772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group.
    Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ;
    J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative.
    Bruera S; Carmona L; Lopez-Olivo MA; Westrich-Robertson T; March L; Negron JB; Christensen R; Strand V; Ingegnoli F; Goel N; Shea B; Tugwell P; Leong A; Bingham CO; Hill CL; Suarez-Almazor ME
    Semin Arthritis Rheum; 2021 Oct; 51(5):1113-1116. PubMed ID: 34446270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions.
    Orbai AM; Halls S; Hewlett S; Bartlett SJ; Leong AL; Bingham CO;
    J Rheumatol; 2015 Nov; 42(11):2182-4. PubMed ID: 25729035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
    Morgan EM; Riebschleger MP; Horonjeff J; Consolaro A; Munro JE; Thornhill S; Beukelman T; Brunner HI; Creek EL; Harris JG; Horton DB; Lovell DJ; Mannion ML; Olson JC; Rahimi H; Gallo MC; Calandra S; Ravelli A; Ringold S; Shenoi S; Stinson J; Toupin-April K; Strand V; Bingham CO
    J Rheumatol; 2017 Dec; 44(12):1884-1888. PubMed ID: 28811355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the similarities and differences of OMERACT core sets using the ICF: first step towards an improved domain specification and development of an item pool to measure functioning and health.
    Escorpizo R; Boers M; Stucki G; Boonen A
    J Rheumatol; 2011 Aug; 38(8):1739-44. PubMed ID: 21807795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018.
    Craig ET; Orbai AM; Mackie S; Bartlett SJ; Bingham CO; Goodman S; Hill C; Holt R; Leong A; Karyekar C; Leung YY; Richards P; Halls S
    J Rheumatol; 2019 Oct; 46(10):1374-1378. PubMed ID: 30770511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders.
    Ramiro S; Page MJ; Whittle SL; Huang H; Verhagen AP; Beaton DE; Richards P; Voshaar M; Shea B; van der Windt DA; Kopkow C; Lenza M; Jain NB; Richards B; Hill C; Gill TK; Koes B; Foster NE; Conaghan PG; Smith T; Malliaras P; Roe Y; Gagnier JJ; Buchbinder R
    J Rheumatol; 2019 Aug; 46(8):969-975. PubMed ID: 30709947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains.
    Maica GL; Iannaccone C; Feathers V; Frits ML; Bykerk VP; Bingham CO; Weinblatt M; Shadick NA
    J Rheumatol; 2023 Jul; 50(7):889-894. PubMed ID: 36725063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.